drugset / Trial / NCT01565590

Effects of Dexmedetomidine on Inflammatory Cytokines in Patients With Aneurysmal Subarachnoid Hemorrhage

NCT01565590

Phase 3 Terminated 4 enrolled University of Cincinnati
RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this research is to compare patients with aneurysmal subarachnoid hemorrhage on dexmedetomidine compared to propofol to assess if one group has decreased inflammation. The investigators hypothesis is that the group assigned to receive dexmedetomidine will have a more profound decrease in markers of inflammation over time.

Timeline

Start
2012-02
Primary completion
2015-07
Completion
2015-07

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 0.2 ug/kg
Subject Dexmedetomidine Other / unclassified 1.5 ug/kg
Comparator Propofol Small molecule 5 ug/kg
Comparator Propofol Small molecule 80 ug/kg